BRCA1 and breast carcinoma: For example, CDDO‐imidazolide has been found to induce G2/M cell cycle arrest in BRCA1‐mutated breast cancer cells [30], and CDDO‐Me has been found to significantly arrest K562 cells in the G2/M and S phases [31].